Terns Pharmaceuticals, Inc. – NASDAQ:TERN

Terns Pharmaceuticals stock price today

$6.31
+0.54
+9.36%
Financial Health
0
1
2
3
4
5
6
7
8
9

Terns Pharmaceuticals stock price monthly change

-38.02%
month

Terns Pharmaceuticals stock price quarterly change

-38.02%
quarter

Terns Pharmaceuticals stock price yearly change

-13.88%
year

Terns Pharmaceuticals key metrics

Market Cap
486.27M
Enterprise value
281.35M
P/E
-7.12
EV/Sales
N/A
EV/EBITDA
-3.27
Price/Sales
N/A
Price/Book
1.52
PEG ratio
-0.29
EPS
-1.26
Revenue
N/A
EBITDA
-102.95M
Income
-91.05M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Terns Pharmaceuticals stock price history

Terns Pharmaceuticals stock forecast

Terns Pharmaceuticals financial statements

Average Price Target
Last Year

$18.67

Potential upside: 195.82%

Based on estimate of 3 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Profit margin
Jun 2023 0 -17.89M
Sep 2023 0 -29.76M
Dec 2023 1.32M -21.01M -1589.94%
Mar 2024 0 -22.37M
Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Debt to assets
Jun 2023 289697000 15.54M 5.37%
Sep 2023 271687000 13.26M 4.88%
Dec 2023 268517000 13.15M 4.9%
Mar 2024 246766000 10.04M 4.07%
Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Cash Flow
Jun 2023 -12.99M -90.83M 489K
Sep 2023 -20.69M -22.31M 20K
Dec 2023 -19.31M 47.23M 13.86M
Mar 2024 -22.79M 7.99M 0

Terns Pharmaceuticals alternative data

Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Employee count
Aug 2023 46
Sep 2023 46
Oct 2023 46
Nov 2023 46
Dec 2023 46
Jan 2024 46
Feb 2024 46
Mar 2024 66
Apr 2024 66
May 2024 66
Jun 2024 66
Jul 2024 66

Terns Pharmaceuticals other data

55.09% -44.91%
of TERN is owned by hedge funds
19.84M -29.87M
shares is hold by hedge funds

Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Insider trades (number of shares)
Period Buy Sel
Apr 2024 0 420663
May 2024 9582 0
Jul 2024 0 127093
Aug 2024 0 15000
Sep 2024 476190 27235
Dec 2024 15450 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BURROUGHS AMY L. director, officer: Chief Execut..
Common Stock 15,450 $7.15 $110,468
Purchase
LU HONGBO director
Common Stock 285,714 $10.5 $2,999,997
Purchase
LU HONGBO director
Common Stock 190,476 $10.5 $1,999,998
Option
VIGNOLA MARK J. officer: Chief Fi.. Common Stock 10,000 $5.36 $53,600
Sale
VIGNOLA MARK J. officer: Chief Fi.. Common Stock 10,000 $11 $110,000
Option
VIGNOLA MARK J. officer: Chief Fi.. Stock Option (Right to Buy) 10,000 $5.36 $53,600
Option
QUIGLEY JILL M. director
Common Stock 17,235 $1.82 $31,368
Sale
QUIGLEY JILL M. director
Common Stock 17,235 $10 $172,350
Option
QUIGLEY JILL M. director
Stock Option (Right to Buy) 17,235 $1.82 $31,368
Sale
QUIGLEY JILL M. director
Common Stock 8,857 $7.5 $66,436
Wednesday, 4 December 2024
marketwatch.com
Tuesday, 3 December 2024
https://thefly.com
marketwatch.com
Monday, 2 December 2024
globenewswire.com
Monday, 18 November 2024
globenewswire.com
Monday, 7 October 2024
globenewswire.com
Wednesday, 25 September 2024
seekingalpha.com
Wednesday, 18 September 2024
fool.com
Sunday, 15 September 2024
fool.com
fool.com
Saturday, 14 September 2024
fool.com
Friday, 13 September 2024
seekingalpha.com
Thursday, 12 September 2024
globenewswire.com
Tuesday, 10 September 2024
globenewswire.com
zacks.com
seekingalpha.com
Monday, 9 September 2024
globenewswire.com
barrons.com
benzinga.com
marketwatch.com
reuters.com
globenewswire.com
Tuesday, 3 September 2024
zacks.com
Wednesday, 28 August 2024
zacks.com
Friday, 2 August 2024
investorplace.com
Monday, 29 July 2024
globenewswire.com
Saturday, 20 July 2024
fool.com
Friday, 21 June 2024
globenewswire.com
Wednesday, 19 June 2024
zacks.com
Tuesday, 4 June 2024
zacks.com
  • What's the price of Terns Pharmaceuticals stock today?

    One share of Terns Pharmaceuticals stock can currently be purchased for approximately $6.31.

  • When is Terns Pharmaceuticals's next earnings date?

    Unfortunately, Terns Pharmaceuticals's (TERN) next earnings date is currently unknown.

  • Does Terns Pharmaceuticals pay dividends?

    No, Terns Pharmaceuticals does not pay dividends.

  • How much money does Terns Pharmaceuticals make?

    Terns Pharmaceuticals has a market capitalization of 486.27M.

  • What is Terns Pharmaceuticals's stock symbol?

    Terns Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "TERN".

  • What is Terns Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Terns Pharmaceuticals?

    Shares of Terns Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Terns Pharmaceuticals's key executives?

    Terns Pharmaceuticals's management team includes the following people:

    • Mr. Senthil Vel Sundaram Chief Executive Officer & Director(age: 47, pay: $581,770)
    • Dr. Erin Quirk M.D. Head of R&D, Pres & Chief Medical Officer(age: 54, pay: $549,390)
    • Dr. Mark Joseph Vignola Chief Financial Officer & Treasurer(age: 47, pay: $402,150)
  • How many employees does Terns Pharmaceuticals have?

    As Jul 2024, Terns Pharmaceuticals employs 66 workers.

  • When Terns Pharmaceuticals went public?

    Terns Pharmaceuticals, Inc. is publicly traded company for more then 4 years since IPO on 5 Feb 2021.

  • What is Terns Pharmaceuticals's official website?

    The official website for Terns Pharmaceuticals is ternspharma.com.

  • Where are Terns Pharmaceuticals's headquarters?

    Terns Pharmaceuticals is headquartered at 1065 East Hillsdale Boulevard, Foster City, CA.

  • How can i contact Terns Pharmaceuticals?

    Terns Pharmaceuticals's mailing address is 1065 East Hillsdale Boulevard, Foster City, CA and company can be reached via phone at +65 05255535.

  • What is Terns Pharmaceuticals stock forecast & price target?

    Based on 3 Wall Street analysts` predicted price targets for Terns Pharmaceuticals in the last 12 months, the avarage price target is $18.67. The average price target represents a 195.82% change from the last price of $6.31.

Terns Pharmaceuticals company profile:

Terns Pharmaceuticals, Inc.

ternspharma.com
Exchange:

NASDAQ

Full time employees:

66

Industry:

Biotechnology

Sector:

Healthcare

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

1065 East Hillsdale Boulevard
Foster City, CA 94404

CIK: 0001831363
ISIN: US8808811074
CUSIP: 880881107